These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35388959)

  • 1. Early dementia diagnosis, MCI-to-dementia risk prediction, and the role of machine learning methods for feature extraction from integrated biomarkers, in particular for EEG signal analysis.
    Rossini PM; Miraglia F; Vecchio F
    Alzheimers Dement; 2022 Dec; 18(12):2699-2706. PubMed ID: 35388959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of the "Cognitive" Brain Wave P3b at Rest for Alzheimer Dementia Prediction in Mild Cognitive Impairment.
    Porcaro C; Vecchio F; Miraglia F; Zito G; Rossini PM
    Int J Neural Syst; 2022 May; 32(5):2250022. PubMed ID: 35435134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer's Disease Spectrum.
    Massetti N; Russo M; Franciotti R; Nardini D; Mandolini GM; Granzotto A; Bomba M; Delli Pizzi S; Mosca A; Scherer R; Onofrj M; Sensi SL; ;
    J Alzheimers Dis; 2022; 85(4):1639-1655. PubMed ID: 34958014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of resting state EEG and structural MRI for classifying Alzheimer's disease and mild cognitive impairment.
    Farina FR; Emek-Savaş DD; Rueda-Delgado L; Boyle R; Kiiski H; Yener G; Whelan R
    Neuroimage; 2020 Jul; 215():116795. PubMed ID: 32278090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of Alzheimer's Disease with Respect to Physiological Aging with Innovative EEG Biomarkers in a Machine Learning Implementation.
    Vecchio F; Miraglia F; Alù F; Menna M; Judica E; Cotelli M; Rossini PM
    J Alzheimers Dis; 2020; 75(4):1253-1261. PubMed ID: 32417784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging and analytical methods for studying the pathways from mild cognitive impairment to Alzheimer's disease: protocol for a rapid systematic review.
    Ahmadzadeh M; Christie GJ; Cosco TD; Moreno S
    Syst Rev; 2020 Apr; 9(1):71. PubMed ID: 32241302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
    J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of advanced machine learning methods on resting-state fMRI network for identification of mild cognitive impairment and Alzheimer's disease.
    Khazaee A; Ebrahimzadeh A; Babajani-Feremi A
    Brain Imaging Behav; 2016 Sep; 10(3):799-817. PubMed ID: 26363784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine Learning-Based Classification of Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Dementia Using Neuroimage and Plasma Biomarkers.
    Chiu SI; Fan LY; Lin CH; Chen TF; Lim WS; Jang JR; Chiu MJ
    ACS Chem Neurosci; 2022 Dec; 13(23):3263-3270. PubMed ID: 36378559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Panel of Plasma Proteins Predicts Progression in Prodromal Alzheimer's Disease.
    Araújo DC; Veloso AA; Gomes KB; de Souza LC; Ziviani N; Caramelli P;
    J Alzheimers Dis; 2022; 88(2):549-561. PubMed ID: 35662125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ensemble of random forests One vs. Rest classifiers for MCI and AD prediction using ANOVA cortical and subcortical feature selection and partial least squares.
    Ramírez J; Górriz JM; Ortiz A; Martínez-Murcia FJ; Segovia F; Salas-Gonzalez D; Castillo-Barnes D; Illán IA; Puntonet CG;
    J Neurosci Methods; 2018 May; 302():47-57. PubMed ID: 29242123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer's disease using EEG technology.
    Jiao B; Li R; Zhou H; Qing K; Liu H; Pan H; Lei Y; Fu W; Wang X; Xiao X; Liu X; Yang Q; Liao X; Zhou Y; Fang L; Dong Y; Yang Y; Jiang H; Huang S; Shen L
    Alzheimers Res Ther; 2023 Feb; 15(1):32. PubMed ID: 36765411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer's Disease.
    Jääskeläinen O; Hall A; Tiainen M; van Gils M; Lötjönen J; Kangas AJ; Helisalmi S; Pikkarainen M; Hallikainen M; Koivisto A; Hartikainen P; Hiltunen M; Ala-Korpela M; Soininen P; Soininen H; Herukka SK
    J Alzheimers Dis; 2020; 74(1):277-286. PubMed ID: 32007958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustainable method for Alzheimer dementia prediction in mild cognitive impairment: Electroencephalographic connectivity and graph theory combined with apolipoprotein E.
    Vecchio F; Miraglia F; Iberite F; Lacidogna G; Guglielmi V; Marra C; Pasqualetti P; Tiziano FD; Rossini PM
    Ann Neurol; 2018 Aug; 84(2):302-314. PubMed ID: 30014515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
    Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
    Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.